Cancer

22 January 2016

Application Invited for the Post of Junior Research Fellow in M. D. University

Maharshi Dayanand University, ab initio established as Rohtak University, Rohtak, came into existence by an Act No. 25 of 1975 of the Haryana Legislative Assembly in 1976 with the objective to promote inter-disciplinary higher education and research in the fields of environmental, ecological and life sciences. It was rechristened as Maharshi Dayanand University in 1977 after the name of a great visionary and social reformer, Maharshi Dayanand. It had a unitary and residential character in its nascent stage, but became an affiliating University in November 1978. The University secured the recognition of University Grants Commission – the higher education regulatory body of India - for central Govt. grants in Feb. 1983.
- Read more about Gum disease linked with breast cancer
Postmenopausal women with periodontal or gum disease are more likely to develop breast cancer than women who do not have the chronic inflammatory disease.
21 December 2015

Vacancy for B.Pharm/M.Pharm in Drug resistant Breast Cancer project at NIN

NIN has attained global recognition for its pioneering studies on various aspects of nutrition research, with special reference to protein energy malnutrition (PEM). Institute’s activities are broad-based, encompassing the whole area of food and nutrition. The Institute has achieved close integration in its research activities between the laboratory, the clinic and the community.
20 December 2015

Career for M.Pharm as Project Fellow at Central University of Rajasthan

The Central University of Rajasthan has been established by an Act of Parliament (Act No. 25 of 2009, The Gazette of India, No. 27, published on 20th March, 2009 as a new Central University, and is fully funded by the Government of India. The President of India, His Excellency Shri Pranab Mukherjee, is the Visitor of the Central University of Rajasthan.
- Read more about Tea consumption reduces risk of cancer: Expert
Consumption of tea, particularly black and green, greatly reduces the risk of cancer in human beings due to the presence of anti-oxidant agents, according to a researcher with a US university.

[adsense:336x280:8701650588]
- Read more about FDA approves Portrazza to treat advanced squamous non-small cell lung cancer
The U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer. Portrazza is marketed by Eli Lilly and Company, based in Indianapolis, Indiana.
- Read more about Pharmacy selling cancer drugs at heavy discount opened
Union Health Minister J.P. Nadda on Sunday inaugurated India's first retail facility at AIIMS to provide drugs for cancer and cardiovascular diseases at highly discounted rates.
- Read more about Drug that could limit spread of deadly brain tumours
Researchers have identified a drug that works to limit the spread of glioblastoma, the most common primary tumour of the brain and central nervous system which is also regarded as one of the most aggressive of all cancers.
- Read more about Middle-income countries bear maximum brunt of cancer deaths
Of the eight million cancer deaths worldwide in 2012, five million occurred in middle-income countries and 500,000 in low-income countries, says a new study led by an Indian-origin researcher.
- Read more about New blood cancer drug shows promise in clinical trial
A new drug can help patients with blood cancers who are resistant to current chemotherapy lead a normal and active life, show results of an international clinical trial, a first-in-man study of the drug.